Johnson & Johnson (JNJ) Long-Term Investments (2009)
Johnson & Johnson's (JNJ) quarterly Long-Term Investments came in at $19.0 million in Q3 2009, up 5.56% quarter-over-quarter from $18.0 million in Q2 2009.
Johnson & Johnson (JNJ) Long-Term Investments (2009) Analysis & Trends
Johnson & Johnson has disclosed Long-Term Investments across 1 years of filings, most recently posting $19.0 million for Q3 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 133.47 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 3.12 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | - |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 268.00 Mn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | 1.11 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 983.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 1.63 Bn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | 366.00 Mn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | 100.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 27, 2009 | 19.00 Mn |
| Jun 28, 2009 | 18.00 Mn |